Furthermore, we analyzed 3550 breast cancer samples in the Kaplan–Meier plotter (http://kmplot.com/analysis/index.php?p=service&cancer=breast (accessed on 14 August 2021)) and showed that low PDK1 expression group had a longer relapse-free survival time than the group with higher PDK1 levels (Figure 1B). This evidence concerns the gene PDK1 and breast carcinoma.